Skip to main content
Search result for "Solr search content"
Search Result for "breast cancer"
Clinical Trial

S2206, Phase III Trial of Neoadjuvant Durvalumab (NSC 778709) plus Chemotherapy versus Chemotherapy Alone for Adults with MammaPrint High 2 Risk (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Bre

This clinical trial aims to validate the results observed in I-SPY2 and will test if adding durvalumab to neoadjuvant chemotherapy can increase pCR rates, shift residual cancer burden to lower values and improve invasive breast cancer free survival in early-stage HRpositive MP2 cancers.

Story

The role of genetic testing in cancer prevention and treatment

Discover how genetic testing at the Mays Cancer Center can guide cancer prevention and treatment. Learn about DNA analysis, personalized risk management, and family implications, as our expert counselors support your journey to proactive, informed cancer care.